|
Volumn 5, Issue 5, 2001, Pages 247-248
|
Continuing HIV therapy in the ICU
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
CYTOCHROME P450 3A4;
CYTOCHROME P450 INHIBITOR;
DIDANOSINE;
LAMIVUDINE;
MIDAZOLAM;
NEVIRAPINE;
NUCLEOSIDE ANALOG;
OPIATE DERIVATIVE;
PHENYTOIN;
PROTEINASE INHIBITOR;
RIFAMPICIN;
STAVUDINE;
ZIDOVUDINE;
ARTICLE;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG WITHDRAWAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPOTENSION;
IMMUNE SYSTEM;
INTENSIVE CARE UNIT;
LACTIC ACIDOSIS;
LIVER DISEASE;
LIVER FAILURE;
METABOLIC DISORDER;
PANCREATITIS;
PATIENT CARE;
PRIORITY JOURNAL;
VIRUS LOAD;
VIRUS REPLICATION;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CONTINUITY OF PATIENT CARE;
HIV INFECTIONS;
HUMANS;
INTENSIVE CARE UNITS;
|
EID: 0034775214
PISSN: 13648535
EISSN: None
Source Type: Journal
DOI: 10.1186/cc1040 Document Type: Article |
Times cited : (12)
|
References (13)
|